ASX - By Stock
|
TRS |
Re:
Ann: Change in substantial holding
|
|
Dazaau
|
21 |
10K |
4 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
21
|
10K
|
4
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Change in substantial holding
|
|
Dazaau
|
21 |
10K |
1 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
21
|
10K
|
1
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Change in substantial holding
|
|
Dazaau
|
21 |
10K |
1 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
21
|
10K
|
1
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Change in substantial holding
|
|
Dazaau
|
21 |
10K |
2 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
21
|
10K
|
2
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Change in substantial holding
|
|
Dazaau
|
21 |
10K |
3 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
21
|
10K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM CEO Presentation
|
|
Dazaau
|
27 |
9.9K |
2 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
27
|
9.9K
|
2
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Completion of equity raise
|
|
Dazaau
|
4 |
3.0K |
1 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
4
|
3.0K
|
1
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Business update
|
|
Dazaau
|
15 |
7.3K |
1 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
15
|
7.3K
|
1
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Entitlement offer booklet, including presentation
|
|
Dazaau
|
6 |
5.5K |
3 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
6
|
5.5K
|
3
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Business update
|
|
Dazaau
|
15 |
7.3K |
1 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
15
|
7.3K
|
1
|
|
ASX - By Stock
|
TRS |
Re:
Ann: Entitlement offer booklet, including presentation
|
|
Dazaau
|
6 |
5.5K |
1 |
15/03/20 |
15/03/20 |
ASX - By Stock
|
6
|
5.5K
|
1
|
|
ASX - By Stock
|
TRS |
Re:
Something is afoot
|
|
Dazaau
|
66 |
366K |
4 |
02/03/20 |
02/03/20 |
ASX - By Stock
|
66
|
366K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
Dazaau
|
289 |
135K |
1 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
289
|
135K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
Dazaau
|
289 |
135K |
0 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
289
|
135K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
Dazaau
|
289 |
135K |
2 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
289
|
135K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
How Wayne Paterson has turned AHZ around....
|
|
Dazaau
|
84 |
43K |
9 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
84
|
43K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
Dazaau
|
289 |
135K |
2 |
17/10/19 |
17/10/19 |
ASX - By Stock
|
289
|
135K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
Dazaau
|
289 |
135K |
7 |
16/10/19 |
16/10/19 |
ASX - By Stock
|
289
|
135K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
Dazaau
|
289 |
135K |
10 |
15/10/19 |
15/10/19 |
ASX - By Stock
|
289
|
135K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
|
|
Dazaau
|
289 |
135K |
5 |
14/10/19 |
14/10/19 |
ASX - By Stock
|
289
|
135K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Dazaau
|
51 |
24K |
1 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
51
|
24K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Dazaau
|
63 |
40K |
0 |
21/09/19 |
21/09/19 |
ASX - By Stock
|
63
|
40K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Dazaau
|
63 |
40K |
1 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
63
|
40K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Dazaau
|
63 |
40K |
0 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
63
|
40K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Dazaau
|
63 |
40K |
4 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
63
|
40K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
1 |
12/09/19 |
12/09/19 |
ASX - By Stock
|
242
|
112K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
10 |
12/09/19 |
12/09/19 |
ASX - By Stock
|
242
|
112K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
1 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
242
|
112K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
0 |
05/09/19 |
05/09/19 |
ASX - By Stock
|
242
|
112K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
1 |
05/09/19 |
05/09/19 |
ASX - By Stock
|
242
|
112K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
1 |
05/09/19 |
05/09/19 |
ASX - By Stock
|
242
|
112K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
4 |
03/09/19 |
03/09/19 |
ASX - By Stock
|
242
|
112K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 3B
|
|
Dazaau
|
4 |
3.2K |
1 |
03/09/19 |
03/09/19 |
ASX - By Stock
|
4
|
3.2K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 3B
|
|
Dazaau
|
4 |
3.2K |
1 |
02/09/19 |
02/09/19 |
ASX - By Stock
|
4
|
3.2K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Dazaau
|
7 |
5.7K |
0 |
02/09/19 |
02/09/19 |
ASX - By Stock
|
7
|
5.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
0 |
30/08/19 |
30/08/19 |
ASX - By Stock
|
242
|
112K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
5 |
26/08/19 |
26/08/19 |
ASX - By Stock
|
242
|
112K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
Dazaau
|
242 |
112K |
3 |
26/08/19 |
26/08/19 |
ASX - By Stock
|
242
|
112K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fee
|
|
Dazaau
|
55 |
32K |
2 |
22/08/19 |
22/08/19 |
ASX - By Stock
|
55
|
32K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fee
|
|
Dazaau
|
55 |
32K |
1 |
22/08/19 |
22/08/19 |
ASX - By Stock
|
55
|
32K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Under the Radar
|
|
Dazaau
|
538 |
239K |
10 |
16/08/19 |
16/08/19 |
ASX - By Stock
|
538
|
239K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Under the Radar
|
|
Dazaau
|
538 |
239K |
0 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
538
|
239K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Under the Radar
|
|
Dazaau
|
538 |
239K |
2 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
538
|
239K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Under the Radar
|
|
Dazaau
|
538 |
239K |
3 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
538
|
239K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice to terminate distribution agreement
|
|
Dazaau
|
40 |
28K |
1 |
09/08/19 |
09/08/19 |
ASX - By Stock
|
40
|
28K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Dazaau
|
40 |
19K |
0 |
05/08/19 |
05/08/19 |
ASX - By Stock
|
40
|
19K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Dazaau
|
40 |
19K |
3 |
05/08/19 |
05/08/19 |
ASX - By Stock
|
40
|
19K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Whatever happened to Herpes?
|
|
Dazaau
|
8 |
6.0K |
4 |
02/08/19 |
02/08/19 |
ASX - By Stock
|
8
|
6.0K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
Dazaau
|
63 |
40K |
10 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
63
|
40K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Extension for Voluntary Suspension
|
|
Dazaau
|
38 |
22K |
5 |
19/07/19 |
19/07/19 |
ASX - By Stock
|
38
|
22K
|
5
|
|